C. Rodríguez‐Antona
Pharmacology · 2007
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Pharmacology — 16 citations into it
- Oncology — 8 citations into it
Whom C. Rodríguez‐Antona trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Magnus Ingelman-Sundberg (in Pharmacology)
Papers from C. Rodríguez‐Antona's perspective
Ordered by how strongly the researchers C. Rodríguez‐Antona trusts endorse each paper. Same corpus, a different order for every researcher.
- Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response (Molecular Psychiatry)
- Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism (Clinical Pharmacokinetics)
- The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution (Science)
- Relative impact of nucleotide and copy number variation on gene expression phenotypes (Science)
- Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression (Nature Genetics)
- Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs (Nature)
- Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity (The Pharmacogenomics Journal)
- Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. (TIPS - Trends in Pharmacological Sciences)
- Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. (The Lancet)
- Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR‐1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus (Clinical pharmacology and therapy)